Artigos relevantes sobre a imagem no mieloma múltiplo:

Rajkumar S.V., Dimopoulos M.A., Palumbo A., Blade J., Merlini G., Mateos M.-V., Kumar S., Hillengass J., Kastritis E., Richardson P., et al. International Myeloma Working Group Updated Criteria for the Diagnosis of Multiple Myeloma. Lancet Oncol. 2014;15:e538–e548. doi: 10.1016/S1470-2045(14)70442-5.

Whole-Body Imaging of Multiple Myeloma: Diagnostic Criteria. Ormond Filho AG, Carneiro BC, Pastore D, Silva IP, Yamashita SR, Consolo FD, Hungria VTM, Sandes AF, Rizzatti EG, Nico MAC.Radiographics. 2019 Jul-Aug;39(4):1077-1097. doi: 10.1148/rg.2019180096.

Moulopoulos LA, Koutoulidis V, Hillengass J, Zamagni E, Aquerreta JD, Roche CL, et al. Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group. Blood Cancer J 2018; 8(10):95.

Hillengass J et al (2019) International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders. Lancet Oncol 20:e302–e312. https://doi.org/10.1016/s1470-2045(19)30309-2.

Messiou C., Hillengass J., Delorme S., Lecouvet F.E., Moulopoulos L.A., Collins D.J., Blackledge M.D., Abildgaard N., Østergaard B., Schlemmer H.-P., et al. Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS) Radiology. 2019;291:5–13. doi: 10.1148/radiol.2019181949.